MRNA vs OTF · rev $145.0M vs rev $1.3M
Moderna Inc (MRNA) versus Blue Owl Technology Finance Corp (OTF) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Blue Owl Technology Finance Corp (OTF) is a asset management company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported OTF revenue for 2025-12-31 was $1.3M. Net income was $720.4M. Revenue was up 4881.5% from 2024-12-31 to 2025-12-31. OTF currently screens at market cap $0.
MRNA currently screens at market cap $24.52B. OTF currently screens at market cap $0.
Not investment advice. Open the MRNA and OTF stock pages for the full models.
Not investment advice.